---
schema_version: "secwatch.filing_event.v1"
accession: "0000896264-24-000138"
form_type: "8-K"
ticker: "USNA"
cik: "0000896264"
company_name: "USANA HEALTH SCIENCES INC"
filed_at: "2024-04-30T23:59:59+00:00"
generated_at: "2026-06-03T05:14:23.859839+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# USANA Q1 net sales $228M (-8% YoY), EPS $0.86, reaffirms FY2024 guidance

## Summary
- Net sales $228M (-8% YoY, -5% constant currency); diluted EPS $0.86 (-9% YoY).
- Reiterates FY2024 net sales outlook $850-920M and EPS $2.40-$3.00.
- Greater China active customers +15% YoY, net sales +3% (+7% constant currency).
- Other key markets declined: North Asia net sales -28% YoY, SE Asia -22%, Americas/Europe -12%.
- Repurchased 194k shares for $9M in Q1; $62M remaining under share repurchase authorization.

## SEC filing metadata
- accession: 0000896264-24-000138
- form_type: 8-K
- ticker: USNA
- cik: 0000896264
- company_name: USANA HEALTH SCIENCES INC
- filed_at: 2024-04-30T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896264/000089626424000138/0000896264-24-000138-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896264/000089626424000138/usna-20240430.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000896264-24-000138
- JSON: https://secwatch.observer/filing/0000896264-24-000138.json
- Plain text: https://secwatch.observer/filing/0000896264-24-000138.txt

## Key facts
- Earnings Releases
  USANA HEALTH SCIENCES INC reported first quarter ended March 30, 2024 results: revenue $228 million, EPS $0.86. Guidance reaffirmed.
  - Period: first quarter ended March 30, 2024
  - Revenue: $228 million
  - EPS: $0.86
  - Guidance: reaffirmed
  - Result: reported results
  source text: Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal first quarter ended March 30, 2024. Key Financial & Operating Results • First quarter net sales were $228 million versus $248 million during Q1 2023, and increased 2% sequentially in constant currency. • First quarter diluted EPS was $0.86 as compared with $0.95 during Q1 2023. • Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/896264/000089626424000138/0000896264-24-000138-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.